Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions

Autor: Mercè Masana, Marianne B. Müller, Christian K.E. Jung, Lidia Blazquez-Llorca, Christiane Volbracht, Anders Brandt Elvang, Saak V. Ovsepian, Jochen Herms, Severin Filser
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Dendritic spine
Time Factors
drug effects [Pyramidal Cells]
Thiazines
Nonsynaptic plasticity
genetics [Amyloid Precursor Protein Secretases]
pharmacology [Enzyme Inhibitors]
chemically induced [Cognitive Dysfunction]
LY2811376
pharmacology [Pyrimidines]
metabolism [Cognitive Dysfunction]
Mice
Cognition
pharmacology [Thiazines]
Amyloid precursor protein
metabolism [Peptide Fragments]
pharmacology [Thiophenes]
Aspartic Acid Endopeptidases
Enzyme Inhibitors
chemistry [Enzyme Inhibitors]
biology
physiology [Pyramidal Cells]
drug effects [Exploratory Behavior]
Pyramidal Cells
physiology [Cognition]
Brain
Long-term potentiation
chemistry [Pyrimidines]
Synaptic Potentials
deficiency [Amyloid Precursor Protein Secretases]
Excitatory postsynaptic potential
drug effects [Brain]
physiology [Synaptic Potentials]
Dendritic Spines
Bace1 protein
mouse

metabolism [Amyloid beta-Peptides]
Mice
Transgenic

pharmacology [Pyrimidinones]
chemistry [Thiazines]
Pyrimidinones
Thiophenes
Neurotransmission
drug effects [Maze Learning]
SCH1682496
Synaptic augmentation
mental disorders
drug effects [Synaptic Potentials]
Animals
Humans
Cognitive Dysfunction
ddc:610
Maze Learning
Biological Psychiatry
deficiency [Aspartic Acid Endopeptidases]
drug effects [Dendritic Spines]
Amyloid beta-Peptides
Dose-Response Relationship
Drug

amyloid beta-protein (1-40)
Peptide Fragments
Mice
Inbred C57BL

Pyrimidines
metabolism [Dendritic Spines]
genetics [Aspartic Acid Endopeptidases]
metabolism [Brain]
Synaptic plasticity
Exploratory Behavior
biology.protein
Amyloid Precursor Protein Secretases
Neuroscience
anatomy & histology [Brain]
Zdroj: Biological psychiatry 77(8), 729-739 (2015). doi:10.1016/j.biopsych.2014.10.013
DOI: 10.1016/j.biopsych.2014.10.013
Popis: Background BACE1 (beta site amyloid precursor protein cleaving enzyme 1) is the rate limiting protease in amyloid β production, hence a promising drug target for the treatment of Alzheimer's disease. Inhibition of BACE1, as the major β-secretase in vivo with multiple substrates, however is likely to have mechanism-based adverse effects. We explored the impact of long-term pharmacological inhibition of BACE1 on dendritic spine dynamics, synaptic functions, and cognitive performance of adult mice. Methods Sandwich enzyme-linked immunosorbent assay was used to assess Aβ40 levels in brain and plasma after oral administration of BACE1 inhibitors SCH1682496 or LY2811376. In vivo two-photon microscopy of the somatosensory cortex was performed to monitor structural dynamics of dendritic spines while synaptic functions and plasticity were measured via electrophysiological recordings of excitatory postsynaptic currents and hippocampal long-term potentiation in brain slices. Finally, behavioral tests were performed to analyze the impact of pharmacological inhibition of BACE1 on cognitive performance. Results Dose-dependent decrease of Aβ40 levels in vivo confirmed suppression of BACE1 activity by both inhibitors. Prolonged treatment caused a reduction in spine formation of layer V pyramidal neurons, which recovered after withdrawal of inhibitors. Congruently, the rate of spontaneous and miniature excitatory postsynaptic currents in pyramidal neurons and hippocampal long-term potentiation were reduced in animals treated with BACE1 inhibitors. These effects were not detected in Bace1 −/− mice treated with SCH1682496, confirming BACE1 as the pharmacological target. Described structural and functional changes were associated with cognitive deficits as revealed in behavioral tests. Conclusions Our findings indicate important functions to BACE1 in structural and functional synaptic plasticity in the mature brain, with implications for cognition.
Databáze: OpenAIRE